A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
Meru Health Program for Cancer Patients With Depression and Anxiety
- Status
- COMPLETED
- Phase
- NA
A Study of LY3457263 in Obese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3526318 in Healthy Male Japanese Participants
- Status
- WITHDRAWN
- Phase
- PHASE1
Incorporating Mind-body Skills With Diabetes Education in Adolescents With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- NA
A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Otoferlin Gene-mediated Hearing Loss Natural History Study
- Status
- RECRUITING
- Phase
- N/A
A Study of Donanemab (LY3002813) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of LY3471851 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
- Status
- COMPLETED
- Phase
- PHASE4
A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Donanemab (LY3002813) in Healthy Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE2
A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1